Stocks and Investing Stocks and Investing
Wed, February 22, 2023
[ 12:00 AM ] - WOPRAI
Daniel Jester Maintained (WK) at Buy with Increased Target to $96 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Rob Oliver Maintained (WK) at Buy with Increased Target to $100 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Bernie McTernan Maintained (WIX) at Strong Buy and Held Target at $100 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Andrew Charles Reiterated (WING) at Buy and Held Target at $180 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (VST) at Buy with Decreased Target to $30 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Josh Milberg Maintained (VLRS) at Buy with Increased Target to $16 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Victor Mizusaki Maintained (VLRS) at Hold with Decreased Target to $14 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
David Coleman Maintained (VMC) at Strong Buy and Held Target at $215 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (XEL) at Hold with Decreased Target to $66 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Nicholas Zangler Reiterated (XPER) at Hold and Held Target at $13 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Matthew Galinko Maintained (XPER) at Strong Buy with Decreased Target to $19 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Dana Telsey Reiterated (WWW) at Hold and Held Target at $14 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AEP) at Buy with Decreased Target to $107 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Dana Telsey Reiterated (AEO) at Hold and Held Target at $17 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AEE) at Hold with Decreased Target to $89 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Ryan Koontz Reiterated (ADTN) at Strong Buy and Held Target at $28 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Paul Silverstein Maintained (ADTN) at Buy with Decreased Target to $31 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Aaron Kessler Downgraded (ZIP) to Buy and Held Target at $26 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Trevor Young Maintained (ZIP) at Buy with Decreased Target to $22 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Alexander Hacking Upgraded (AA) to Strong Buy and Increased Target to $65 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Erik Suppiger Reiterated (BLZE) at Buy and Held Target at $18 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Yi Chen Reiterated (BLTE) at Strong Buy and Held Target at $58 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Leland Gershell Downgraded (BMRN) to Hold on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Charlie Chan Downgraded (ACMR) to Sell and Held Target at $10 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Tiago Fauth Reiterated (ABCL) at Buy and Held Target at $34 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Gary Nachman Maintained (ABCL) at Buy with Decreased Target to $32 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Tim Anderson Downgraded (ABBV) to Hold on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Christopher Growe Maintained (CAG) at Hold with Decreased Target to $40 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Joshua Long Reiterated (CAKE) at Buy and Held Target at $38 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Drew Ranieri Maintained (AVNS) at Sell with Increased Target to $28 on, Feb 22nd, 2023

Drew Ranieri Maintained (AVNS) at Sell with Increased Target to $28 on, Feb 22nd, 2023


Published on 2024-10-28 01:48:13 - WOPRAI, Drew Ranieri
  Print publication without navigation


Drew Ranieri of Morgan Stanley, Maintained "Avanos Medical, Inc." (AVNS) at Sell with Increased Target from $26 to $28 on, Feb 22nd, 2023.

Drew has made no other calls on AVNS in the last 4 months.



There is 1 other peer that has a rating on AVNS. Out of the 1 peers that are also analyzing AVNS, 0 agree with Drew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Drew

  • Matthew Mishan of "Keybanc" Maintained at Buy with Decreased Target to $34 on, Thursday, November 3rd, 2022
Contributing Sources